FDA approves new version of diabetes drug Mounjaro for weight loss ...Middle East

A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced Wednesday. The U.S. Food and Drug Administration approved Eli Lilly’s drug, named Zepbound. The drug, also known as tirzepatide, helped dieters lose as much as 40 to 60 pounds in testing. Zepbound is the latest diabetes drug approved for chronic weight management, joining Novo Nordisk’s Wegovy, a high-dose version of its diabetes treatment Ozempic. Both are weekly injections. The FDA approved Lilly’s drug for people who are considered obese, with a body mass index of 30 or higher, or those who are overweight with a related health condition, like high blood pressure, high chol

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA approves new version of diabetes drug Mounjaro for weight loss )

Also on site :

• Over 20 Palestinians, children included, killed in Israeli airstrikes in Gaza
• Dem Bulb: Scott Jennings Laughs that Failure of Fake Biden Town Hall Was Blamed on Bad Lighting
• Suspect search underway after woman shot on West El Camino Avenue in Natomas